Skip to main content

HomeLegalGHK-Cu in Pennsylvania

Educational — Not Legal AdviceUpdated

GHK-Cu in Pennsylvania: Legal Status & Provider Guide (2026)

Quick Answer

GHK-Cu is available without a prescription in some forms in the United States. GHK-Cu is not FDA-approved. Topical applications are available without prescription. Injectable formulations are compounded under physician oversight. Its status as a naturally occurring peptide distinguishes it from fully synthetic research compounds. In Pennsylvania, compounding is governed by the Pennsylvania State Board of Pharmacy (PSBP). Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.

Federal Legal Status

FDA Approval Status

GHK-Cu is not FDA-approved as a drug. It is a naturally occurring copper-binding peptide present in human plasma. In cosmetic formulations, it is used without prescription. Injectable or prescription GHK-Cu requires a physician's order and compounding pharmacy.

Compounding Pharmacy Rules (Federal)

GHK-Cu can be compounded by 503A pharmacies under a valid prescription. It is not on the FDA 503A or 503B bulk substances lists as a designated substance, but it is a naturally occurring peptide (not a synthetic novel compound), which has historically resulted in more permissive treatment by some pharmacy boards. Cosmetic (topical) applications are widely available without a prescription.

Also Known As

Copper Peptide GHK-Cu · Glycyl-L-histidyl-L-lysine copper · GHK

Primary Research Areas

  • Wound healing
  • Skin repair
  • Hair growth
  • Anti-inflammatory effects
  • Anti-aging

Pennsylvania Pharmacy Board & Compounding Rules

Compounding Overview

Pennsylvania's State Board of Pharmacy regulates compounding pharmacies with detailed sterile and non-sterile compounding standards. Pennsylvania has historically been home to several large-scale compounding operations. The state enforces USP 797 standards for sterile products and requires annual inspections for high-risk compounding. Pennsylvania is part of the northeastern corridor with significant demand from New York, New Jersey, and Delaware markets.

Notable Rules

  • Pennsylvania requires pharmacies engaged in sterile compounding to have a separate license category.
  • Annual inspections are required for pharmacies performing high-risk sterile compounding.
  • Pennsylvania shares regulatory burden with the FDA for pharmacies also registered as 503B outsourcing facilities.
  • Non-resident pharmacies shipping compounds into Pennsylvania must be registered with the PSBP.
  • Pennsylvania and New York maintain some reciprocal licensing arrangements for pharmacy professionals.

Prescribing Requirements in Pennsylvania

Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.

About GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide that binds copper ions. It is found in human plasma, saliva, and urine, declining with age. Research has focused on skin repair, anti-inflammatory effects, and potential neuroprotective properties.

For more research information, mechanism of action, and provider availability, see the GHK-Cu research profile on PeptideBase.

Frequently Asked Questions

Is GHK-Cu available without a prescription?
Topical GHK-Cu (creams, serums) is widely available without a prescription. Injectable or infused GHK-Cu requires a physician's prescription and compounding pharmacy. The topical form is regulated as a cosmetic, not a drug.

GHK-Cu Providers in Pennsylvania

5 providers in the PeptideBase directory offer GHK-Cu in Pennsylvania. Always verify current offerings directly with the provider.

GHK-Cu Legal Status in Other States

Pharmacy board rules and compounding regulations vary by state. Compare GHK-Cu legal status across other major markets:

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.